TME Pharma N.V. (ALTME) — Financial Flexibility Index
TME Pharma N.V. (ALTME) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of €-557.00K (operating CF €-557.00K minus capex €0.00) represents 0% of total liabilities (€3.72 Million). Also explore TME Pharma N.V. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TME Pharma N.V. Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for TME Pharma N.V. across 12 annual periods. Check asset allocation strategy of TME Pharma N.V. to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for TME Pharma N.V. (2014–2025)
Year-by-year free cash flow to debt coverage for TME Pharma N.V.. For the full company profile including market capitalisation, see how much is TME Pharma N.V. worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.92x | €-3.42 Million | €-3.42 Million | €3.72 Million | ▲ +64.3% |
| 2024 | -2.58x | €-4.62 Million | €-4.63 Million | €1.79 Million | ▼ -27.8% |
| 2023 | -2.02x | €-5.62 Million | €-5.63 Million | €2.79 Million | ▼ -8.3% |
| 2022 | -1.86x | €-12.12 Million | €-12.14 Million | €6.51 Million | ▲ +20.7% |
| 2021 | -2.35x | €-12.37 Million | €-12.38 Million | €5.27 Million | ▼ -33.9% |
| 2020 | -1.75x | €-5.18 Million | €-5.22 Million | €2.96 Million | ▼ -47.3% |
| 2019 | -1.19x | €-4.27 Million | €-4.29 Million | €3.59 Million | ▼ -112.6% |
| 2018 | -0.56x | €-3.99 Million | €-4.00 Million | €7.12 Million | ▲ +35.9% |
| 2017 | -0.87x | €-4.24 Million | €-4.24 Million | €4.85 Million | ▲ +47.9% |
| 2016 | -1.68x | €-8.97 Million | €-8.99 Million | €5.35 Million | ▼ -62.6% |
| 2015 | -1.03x | €-13.47 Million | €-13.48 Million | €13.07 Million | ▲ +22.5% |
| 2014 | -1.33x | €-12.41 Million | €-12.46 Million | €9.33 Million | — |